HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshikazu Nakamura Selected Research

Parkinson Disease (Parkinson's Disease)

1/2017Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
1/2011Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshikazu Nakamura Research Topics

Disease

8Neoplasms (Cancer)
01/2023 - 01/2005
7Inflammation (Inflammations)
01/2023 - 05/2007
5Macular Degeneration (Age-Related Maculopathy)
12/2023 - 09/2019
4Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
07/2010 - 04/2004
3Lung Neoplasms (Lung Cancer)
09/2022 - 10/2018
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017 - 07/2012
3Infections
12/2016 - 02/2010
3Obesity
11/2015 - 07/2011
3Breast Neoplasms (Breast Cancer)
06/2011 - 11/2009
2B-Cell Lymphoma (Lymphoma, B Cell)
03/2024 - 01/2013
2Prion Diseases (Transmissible Spongiform Encephalopathies)
03/2023 - 08/2015
2Neoplasm Metastasis (Metastasis)
01/2023 - 10/2021
2Fibrosis (Cirrhosis)
09/2022 - 09/2019
2Achondroplasia
01/2021 - 01/2021
2Hypertension (High Blood Pressure)
01/2021 - 07/2010
2Leukemia
11/2020 - 09/2004
2Myocardial Infarction
03/2019 - 01/2019
2Contact Dermatitis (Eczema, Contact)
01/2019 - 01/2019
2Skin Diseases (Skin Disease)
01/2019 - 07/2012
2Parkinson Disease (Parkinson's Disease)
01/2017 - 01/2011
2Disease Progression
11/2016 - 01/2011
2Hyperplasia
06/2015 - 05/2007
2Colonic Neoplasms (Colon Cancer)
05/2014 - 05/2011
2Neuroblastoma
02/2013 - 03/2011
2Carcinogenesis
01/2013 - 03/2008
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
02/2011 - 03/2008
1Gerstmann-Straussler-Scheinker Disease
03/2023
1Sporadic Creutzfeldt-Jakob Disease
03/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022
1Dwarfism
01/2021
1Respiratory Syncytial Virus Infections
01/2021
1Down Syndrome (Down's Syndrome)
01/2021
1Adenocarcinoma of Lung
10/2019
1Cicatrix (Scar)
09/2019
1Choroidal Neovascularization
09/2019
1Retinal Diseases
09/2019
1Heart Failure
03/2019
1Heart Arrest (Cardiac Arrest)
01/2019
1IGA Glomerulonephritis (IGA Nephropathy)
06/2017
1Hematuria
06/2017
1Lupus Nephritis
06/2017
1Nephrotic Syndrome (Syndrome, Nephrotic)
06/2017
1Proteinuria
06/2017
1Vitreous Detachment (Posterior Vitreous Detachment)
05/2017
1Retinal Perforations
05/2017

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
10/2021 - 12/2010
6Phospholipases (Phospholipase)IBA
01/2019 - 05/2007
5Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2023 - 11/2016
5Nucleotide AptamersIBA
01/2021 - 03/2008
4CytokinesIBA
03/2024 - 02/2011
4Codon (Codons)IBA
03/2023 - 11/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2023 - 09/2019
3RNA (Ribonucleic Acid)IBA
12/2016 - 02/2010
3Interleukin-17 (Interleukin 17)IBA
06/2015 - 02/2011
3Phosphatidylinositols (Phosphatidylinositol)IBA
07/2011 - 07/2010
3LipidsIBA
01/2011 - 11/2009
2LigandsIBA
01/2021 - 05/2011
2Warfarin (Coumadin)FDA LinkGeneric
01/2019 - 07/2010
2Irritants (Vesicants)IBA
01/2019 - 01/2019
2Immunoglobulin A (IgA)IBA
06/2017 - 02/2010
2Prednisolone (Predate)FDA LinkGeneric
06/2017 - 01/2011
2Imiquimod (Aldara)FDA LinkGeneric
01/2017 - 06/2015
2Calcitriol Receptors (Calcitriol Receptor)IBA
01/2017 - 05/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2015 - 01/2011
2Methionine (L-Methionine)FDA Link
08/2015 - 11/2007
2CholesterolIBA
08/2015 - 11/2009
2Heparin (Liquaemin)FDA LinkGeneric
02/2013 - 03/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2013 - 03/2008
2MidkineIBA
02/2013 - 03/2008
2EnzymesIBA
07/2011 - 07/2010
2P-2 (P 2)IBA
05/2011 - 07/2010
2AntibodiesIBA
01/2011 - 02/2010
2Immunoglobulin M (IgM)IBA
01/2011 - 02/2010
1Investigational DrugsIBA
12/2023
1Immunoglobulin E (IgE)IBA
01/2023
1Thromboplastin (Tissue Factor)IBA
01/2023
1AnticoagulantsIBA
01/2023
1FibrinIBA
01/2023
1Gefitinib (Iressa)FDA Link
09/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2022
1Tyrosine Kinase InhibitorsIBA
09/2022
1Therapeutic UsesIBA
09/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021
1PalivizumabFDA Link
01/2021
1Monoclonal AntibodiesIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
11/2020
1Virulence Factors (Pathogenicity Factors)IBA
10/2020
1pegaptanib (Macugen)FDA Link
11/2019
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2019
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2019
1ChemokinesIBA
10/2019
1Chymases (Chymase)IBA
03/2019
1mizoribineIBA
06/2017

Therapy/Procedure

5Therapeutics
11/2023 - 01/2011
1Intravitreal Injections
11/2023
1Subcutaneous Injections
01/2021
1Lasers (Laser)
09/2019
1Scleral Buckling
05/2017
1Light Coagulation
05/2017
1Speech Therapy (Therapy, Speech)
03/2017